|
Pharmaxis Ltd - Company Profile Snapshot
| Company Profile: |
Pharmaxis Ltd |
| Ticker: |
PXS |
| Exchanges: |
MBE SYD |
| 2009 Sales: |
595,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
AUSTRALIA |
| Employees: |
41 |
Business Description
Pharmaxis Ltd. The Group's principal activities are researching, developing and commercializing human healthcare products for the treatment and management of chronic respiratory and immune disease. Products include Aridol and Bronchitol. Aridol is designed to help doctors diagnose and manage asthma by detecting active airway inflammation through measuring airway hyper-responsiveness. Bronchitol is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The Group operates predominantly in Australia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
